Abstract P3-09-11: Modulation of the immune microenvironment in high risk DCIS

作者
Michael J. Campbell,Jasmine Wong,Emma McCune,Harriet Rothschild,Tristan Loveday,Jennifer Bolen,Cliff C. Hoyt,Scott R. VandenBerg,Jo Chien,Laura J. Esserman
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:80 (4_Supplement): P3-09
标识
DOI:10.1158/1538-7445.sabcs19-p3-09-11
摘要

Abstract Background. Ductal carcinoma in situ (DCIS) is a risk factor for the subsequent development of invasive breast cancer. Features of DCIS that are associated with a high risk of a subsequent event include large size (> 5 cm), high grade, comedo necrosis, palpable mass, hormone receptor negativity, and HER2 positivity. We have previously shown that immune infiltrates in DCIS are positively associated with these high-risk features, suggesting that manipulating the immune microenvironment in high risk DCIS could potentially alter disease progression. Objectives. The objectives of this study were: 1). to define dose limiting toxicities, tolerability, and feasibility of intralesional injection of an immune checkpoint inhibitor (pembrolizumab) into DCIS; and 2). to determine response rate as measured by an increase in total T cells or CD8+ T cells from baseline to post treatment. Methods. Study participants received 2 intralesional injections of pembrolizumab, 3 weeks apart, with surgery approximately 3 weeks after the 2nd dose. Multiplex immunofluorescence analyses were used to compare immune cell populations in pre-treatment biopsies to post-treatment surgical specimens. Tissue samples were stained with two 6-plex immune panels using Opal immunofluorescence reagents (Perkin Elmer) on a fully automated Ventana Discovery platform, imaged with a Vectra 3 system and analyzed with inForm software (Perkin Elmer). Results. The intralesional injections were well tolerated and there were no systemic toxicities observed. Multiplex immunofluorescence analyses demonstrated significant increases in total T cells, as well as cytotoxic CD8+ T cells, following therapy. We also observed a significant positive correlation between the change (pre- vs. post-therapy) in Ki67+ T cells (proliferating T cells) with the increase in total T cells, suggesting that immune checkpoint inhibition removed the “brakes” from the T cells, allowing them to proliferate. Changes in macrophage, B cell, and Treg numbers pre- vs. post-therapy were not significant. Despite an increase in T cell infiltrates, there were no measurable indicators of an anti-tumor response: no reduction in lesion size by MRI, no reduction in proliferation of DCIS cells (Ki67 staining), and no increase in cell death (cleaved caspase 3 staining). Spatial analyses indicated that in most cases the T cell expansion (both total T cells and CD8+ T cells) occurred predominantly in the stroma, not among the DCIS cells in the ducts. Conclusions. We met the objectives of our study: 1). we demonstrated the safety and feasibility of intralesional injection of an immune checkpoint inhibitor (pembrolizumab) in high risk DCIS; and 2). we demonstrated that local immunotherapy resulted in the local proliferation/expansion of T cells. However we did not observe any change in the size of the lesions by MRI. In addition, there was no evidence for T cell killing at the cellular level, suggesting that even though there was an expansion of T cells, there are other factors at play such as immune exclusion or possibly immunosuppression of their killing ability. These results suggest that combination of pembrolizumab with another agent(s) will be needed to achieve a more complete response. Citation Format: Michael Campbell, Jasmine Wong, Emma McCune, Harriet Rothschild, Tristan Loveday, Jennifer Bolen, Cliff Hoyt, Scott VandenBerg, Jo Chien, Laura Esserman. Modulation of the immune microenvironment in high risk DCIS [abstract]. In: Proceedings of the 2019 San Antonio Breast Cancer Symposium; 2019 Dec 10-14; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2020;80(4 Suppl):Abstract nr P3-09-11.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
7秒前
king完成签到 ,获得积分10
9秒前
10秒前
153266916完成签到 ,获得积分10
14秒前
文文发布了新的文献求助10
16秒前
韩梅完成签到 ,获得积分10
20秒前
活力尔柳完成签到 ,获得积分10
22秒前
23秒前
起名困难户完成签到,获得积分10
25秒前
u雨发布了新的文献求助10
29秒前
小周完成签到 ,获得积分10
30秒前
齐天小圣完成签到 ,获得积分10
37秒前
u雨完成签到,获得积分10
39秒前
困困困完成签到,获得积分10
41秒前
忧伤的白秋完成签到,获得积分10
41秒前
勤劳的乐蕊完成签到,获得积分10
44秒前
噜噜晓完成签到 ,获得积分10
46秒前
呆橘完成签到 ,获得积分10
47秒前
踏实谷蓝完成签到 ,获得积分10
49秒前
林韵悠扬完成签到 ,获得积分10
50秒前
土豆完成签到 ,获得积分10
51秒前
科研蛀虫完成签到 ,获得积分10
51秒前
黎咩e茹完成签到,获得积分10
51秒前
53秒前
苗条的奇异果完成签到,获得积分10
55秒前
细心又菡发布了新的文献求助10
1分钟前
腼腆的眼睛完成签到 ,获得积分10
1分钟前
沙莎完成签到 ,获得积分10
1分钟前
CodeCraft的应助被细心又菡采纳,获得10
1分钟前
meilirenshengzcs完成签到,获得积分10
1分钟前
石头完成签到 ,获得积分10
1分钟前
张长剑完成签到,获得积分10
1分钟前
chaosyw完成签到,获得积分10
1分钟前
Lucas的应助被张长剑采纳,获得10
1分钟前
黄锐完成签到 ,获得积分10
1分钟前
yeeja完成签到 ,获得积分10
1分钟前
冷静青枫完成签到,获得积分10
1分钟前
小胖wwwww完成签到 ,获得积分10
1分钟前
梦安完成签到 ,获得积分10
1分钟前
七夜完成签到 ,获得积分10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180068
求助须知:如何正确求助?哪些是违规求助? 9570224
关于积分的说明 21808724
捐赠科研通 7776054
什么是DOI,文献DOI怎么找? 3433261
关于科研通互助平台的介绍 2557425
邀请新用户注册赠送积分活动 2479012